Translating chemometric analysis into physiological insights from in vivo confocal Raman spectroscopy of the human stratum corneum.


Journal

Biochimica et biophysica acta. Biomembranes
ISSN: 1879-2642
Titre abrégé: Biochim Biophys Acta Biomembr
Pays: Netherlands
ID NLM: 101731713

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 23 04 2018
revised: 31 10 2018
accepted: 16 11 2018
pubmed: 23 11 2018
medline: 20 9 2019
entrez: 23 11 2018
Statut: ppublish

Résumé

The superficial layer of the skin, the stratum corneum (SC), consists of corneocytes surrounded by lipid regions and acts as a protective barrier for the body against water loss, toxic agents and microorganisms. As most substances permeate the stratum corneum through the lipid regions, lipid organization is considered crucial for the skin barrier function. Here, we investigate the potential of in vivo confocal Raman spectroscopy to describe the composition and organization of the SC. Confocal Raman spectroscopy is finding increasing use in the characterization of skin in biomedical, pharmaceutical and cosmetic applications. In this work, we analyze the spectra using chemometric methods and obtain principal components that correspond to the primary skin constituents: protein (keratin), natural moisturizing factor (NMF), water and lipid contributions in both ordered (orthorhombic) and disordered structural organization. By identifying these important components of the SC, these results highlight the utility of this in vivo, non-invasive, and depth resolved tool at the forefront of skin research.

Identifiants

pubmed: 30465747
pii: S0005-2736(18)30345-6
doi: 10.1016/j.bbamem.2018.11.007
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-409

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Stefania Perticaroli (S)

The Procter and Gamble Company, Research and Development, Mason Business Center, Cincinnati, OH 45040, USA. Electronic address: perticaroli.s@pg.com.

Dawn J Yeomans (DJ)

The Procter and Gamble Company, Research and Development, Sharon Woods Technical Center, Cincinnati, OH 45241, USA.

Fred C Wireko (FC)

The Procter and Gamble Company, Research and Development, Mason Business Center, Cincinnati, OH 45040, USA.

John T Webber (JT)

The Procter and Gamble Company, Research and Development, Mason Business Center, Cincinnati, OH 45040, USA.

Kathy M Werchowski (KM)

The Procter and Gamble Company, Research and Development, Sharon Woods Technical Center, Cincinnati, OH 45241, USA.

R Thomas Cambron (RT)

The Procter and Gamble Company, Research and Development, Mason Business Center, Cincinnati, OH 45040, USA.

Paula J Ray (PJ)

The Procter and Gamble Company, Research and Development, Mason Business Center, Cincinnati, OH 45040, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH